CD19 and non-small cell lung carcinoma: No differences were found in CD19+ B cells (7.46; IQR 3.06 vs. 6.61; IQR 5.29), antibody-secreting cells (3.48; IQR 3.67 vs. 1.90 IQR 2.67), CD27(−) cells (73.90; IQR 20.38 vs. 78.30; IQR 21.45) and memory lymphocytes (16.90; IQR 20.56 vs. 21.40; IQR 17.45) between NSCLC patients and healthy subjects (Supplementary Figure S3).